IRadimed Corporation (IRMD) |
| 82.22 0.35 (0.43%) 09-11 16:00 |
| Open: | 82.99 |
| High: | 83.89 |
| Low: | 81.62 |
| Volume: | 251,321 |
| Market Cap: | 1,051(M) |
| PE Ratio: | 41.32 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 93.08 |
| Resistance 1: | 88.62 |
| Pivot price: | 85.70 |
| Support 1: | 81.40 |
| Support 2: | 67.73 |
| 52w High: | 107.9 |
| 52w Low: | 67.842 |
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
| EPS | 1.790 |
| Book Value | 7.960 |
| PEG Ratio | 0.00 |
| Gross Profit | 5.121 |
| Profit Margin (%) | 26.70 |
| Operating Margin (%) | 31.23 |
| Return on Assets (ttm) | 15.6 |
| Return on Equity (ttm) | 23.5 |
Fri, 11 Sep 2026
Is IRADIMED (IRMD) Overvalued After A 157% Five Year Run? - simplywall.st
Fri, 11 Sep 2026
How (IRMD) Movements Inform Risk Allocation Models - Stock Traders Daily
Tue, 08 Sep 2026
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com Nigeria
Tue, 08 Sep 2026
Director at IRADIMED (IRMD) sells 1,419 shares - Stock Titan
Tue, 08 Sep 2026
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com South Africa
Fri, 04 Sep 2026
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100 - GuruFocus
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |